ARTICLE | Financial News

Celularity launches with undisclosed series A

September 1, 2017 3:18 PM UTC

Celularity Inc. (Warren, N.J.) launched on Aug. 21 with an undisclosed series A round, as well as assets and IP, from Sorrento Therapeutics Inc. (NASDAQ:SRNE), United Therapeutics Corp. (NASDAQ:UTHR), Human Longevity Inc. (San Diego, Calif.) and additional undisclosed investors.

The newco is developing placenta-derived cell therapies to treat cancer and chronic and degenerative diseases...

BCIQ Company Profiles

Celularity Inc.